The discovery that low CTNNA1 expression is associated with a higher degree of bladder cancer progression, accompanied with the discovery that the CTNNA1 pathway exists in the exosomes of bladder cancer cells, will facilitate future studies on CTNNA1 in other cancer types (Fig. 3B). Here, CTNNA1 is linked to urinary bladder carcinoma.